Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (9)

2024

  1. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology, Vol. 19, Núm. 11, pp. 1597-1611

2023

  1. Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 12, pp. 985-995

2022

  1. Multi-omics signatures of the human early life exposome

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Variability of multi-omics profiles in a population-based child cohort

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children

    BMC Medicine, Vol. 18, Núm. 1

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

    Journal of Cheminformatics, Vol. 9, Núm. 1

2009

  1. Inflammatory activation and left ventricular mass in essential hypertension

    American Journal of Hypertension, Vol. 22, Núm. 4, pp. 444-450